CPhI & P-MEC India: Bringing Pharmaceutical Solutions To The Market In North India For The First Time


The 12th edition of CPhI India and P-MEC India brought latest solutions from the Pharma sector to the attendees of the expo at India Expo Centre, Gr. Noida from 12th-14th December, 2018. Incepted in 2006 by organisers UBM India Pvt. Ltd., CPhI India and P-MEC have been held in Mumbai for more than a decade, catering to the Pharma Industry in South India. The event was held simultaneous to the India Pharma Week which began on 9th December, 2018 and concluded on 14th December, 2018. Chemistry Today were partners for the event.

Indian pharmaceutical sector supplies over 50 per cent of global demand for various vaccines, 40 per cent of generic demand in the US and 25 per cent of all medicine in UK. India contributes the second largest share of pharmaceutical and biotech workforce in the world. Clearly, the Pharmaceutical Industry in India impacts the industry in many other nations as well. With more than 1600 exhibitors, the exhibition covered an area of 235000 sqm. and contributed majorly to the global pharmaceutical industry. Exhibitors at the event included pharma ingredients manufacturers, pharmaceutical machinery, laboratory equipment and analytical technology. Special pavilions by Pharmexcil, CCCMHPI & CCPIT were also set up in this edition. On-site events at the Pharma week like Supplier Finder, CPhI TV, Mobile Apps, Tech Walls, Matchmaking – Live Pharma Connect, Exhibitor Showcase, and Innovation Gallery among others made the visitors experience an engaging and memorable one.

Speaking on IPW 2018, Yogesh Mudras, Managing Director, UBM India said, “The shift to the region, in close geographical proximity to the Centre, policy makers, consulates and government bodies will enhance our community building efforts. With an estimated spend of over US$ 200 billion on medical infrastructure in the next decade; India is keen to make drugs affordable as well as available in all corners of the country.

“What is also equally required to make India a global leader in end to end pharma manufacturing, as encapsulated by The ‘Pharma Vision 2020’ is a heightened appreciation and awareness about compliance requirements and investment in R&D. These factors seem to have been comprehended by the pharma community with around 9 per cent of sales by organisations being re-invested in R&D and 46 mergers having been affected in 2017-18. These will, no doubt, go a long way in leading the country on to further innovation, discovery and patents to maintain its stronghold over the sector,” Yogesh Mudras added.

The Pharma Week focused on Business, Leadership, Knowledge, Innovation, Networking and Recognition. More than 7 events were organised during the week, leaving no stone unturned.

As a tribute to the city in which it was born and reared, the India Pharma Week was commenced with Pharma Leaders Golf in Mumbai on 9th December, 2018. Innumerable business opportunities and contacts were built over a friendly round of golf.
Pharma Connect Congress themed ‘Ideate. Innovate. Integrate’ included discussions on ‘Transforming the Pharma Industry Architect Through Collaborations’ & ‘Strategies to Strengthen Regulatory Policies in India’ amongst other topics.
Closed door CEO Roundtable was a strategic gathering of CEOs of leading Pharma companies.
India Pharma Awards were also held on the same day.
Women in Pharma were appreciated and recognised for their contribution on the next day. Women luminaries from the world of pharmaceuticals, biopharmaceuticals, and life sciences came together on a common platform to share their success stories, experiences, and knowledge. Revolving on 3 core pillars; leadership, entrepreneurship and gender diversity; the speakers discussed topics like ‘Can Women have it all? Balancing Life and Work.’The show provided an opportunity to meet with experts from more than 122 countries.

Over the years, the exhibitions have been approved and comprehensively assisted in its endeavours by governing bodies such as Pharmexcil, CIPI and IDMA. The Government of India plans to set up a US$ 640 million venture capital fund to boost drug discovery and strengthen pharmaceutical infrastructure. The ‘Pharma Vision 2020’ by the government’s Department of Pharmaceuticals aims to make India a major hub for end-to-end drug discovery. Therefore, the Pharmaceutical sector in India is rapidly growing and exhibitions that bring in latest technologies and innovation in the industry are aiding it.


Please enter your comment!
Please enter your name here